Skip to content

Clinical trials

Rare Diseases trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rare Diseases Country / region: United Kingdom Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20061
20071
20133
20152
20161
20171
20181
20201
20211
20222
20233
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Not yet recruiting3
Recruiting3
Active, not recruiting2
Enrolling by invitation1
Suspended1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Associazione Angela Serra per la ricerca sul cancro2
Gemma Biotherapeutics2
Laboratoire français de Fractionnement et de Biotechnologies2
Novartis Pharmaceuticals2
Ultragenyx Pharmaceutical Inc2
Amgen1
Boston University1
Friedreich's Ataxia Research Alliance1
National Center for Research Resources (NCRR)1
NightstaRx Ltd, a Biogen Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Rare Diseases25
Friedreich Ataxia3
Genetic Diseases, Inborn3
Lysosomal Storage Diseases3
Neurodegenerative Diseases3
Ataxia2
Hematologic Diseases2
Huntington Disease2
Metabolic Diseases2
Peripheral Nervous System Diseases2

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.